Immuno-Oncology Database and Bioregistry

Active, not recruitingOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

May 20, 2021

Primary Completion Date

June 4, 2026

Study Completion Date

June 4, 2026

Conditions
MalignancyImmune System DiseasesAutoimmune Diseases
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of cheek swab, blood, urine, stool, and tissue samples for research

OTHER

Medical Chart Review

Periodic review of medical records for clinical parameters (labs, ICI dosing and frequency, occurrence, timing and type of irAE, irAE management, etc.) along with relevant demographic information (age, sex/gender, race/ethnicity, insurance type, etc.).

OTHER

Questionnaires/Surveys

Periodic self-report questionnaires/surveys for symptom tracking, quality of life, perinatal outcomes, etc.

Trial Locations (1)

27599

Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

University of North Carolina, Chapel Hill

OTHER

collaborator

North Carolina Translational and Clinical Sciences Institute

OTHER

lead

UNC Lineberger Comprehensive Cancer Center

OTHER

NCT04656873 - Immuno-Oncology Database and Bioregistry | Biotech Hunter | Biotech Hunter